Otsuka Beijing Research Institute
Clinical trials sponsored by Otsuka Beijing Research Institute, explained in plain language.
-
Healthy men test Single-Dose drug in early safety study
Knowledge-focused CompletedThis early-phase study looked at how a single 7.5 mg dose of tolvaptan behaves in the body of 10 healthy men aged 18 to 40. The goal was to measure drug levels and check for side effects, not to treat any disease. Results help researchers understand the drug's safety and processi…
Phase: PHASE1 • Sponsor: Otsuka Beijing Research Institute • Aim: Knowledge-focused
Last updated May 26, 2026 07:00 UTC
-
Healthy men test drug dosing in Early-Stage safety study
Knowledge-focused CompletedThis study looked at how a drug called tolvaptan behaves in the body and whether it is safe when taken multiple times. It involved 12 healthy men aged 18 to 40. The goal was to measure drug levels and side effects, not to treat any disease.
Phase: PHASE1 • Sponsor: Otsuka Beijing Research Institute • Aim: Knowledge-focused
Last updated May 26, 2026 06:51 UTC
-
Healthy men test new Drug's body chemistry
Knowledge-focused CompletedThis study looked at how the drug Tolvaptan is processed in the bodies of 64 healthy men. One group took a single dose, and another took multiple doses. Researchers measured drug levels in the blood to understand its breakdown and elimination. The study did not treat any disease,…
Phase: PHASE1 • Sponsor: Otsuka Beijing Research Institute • Aim: Knowledge-focused
Last updated May 26, 2026 06:42 UTC